Cargando…

Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent report

Anderson-Fabry disease (AFD) is a rare lysosomal storage disorder. Randomized controlled clinical trials (RCTs) are preferred as the highest category of evidence, but limited availability of robust evidence in rare diseases may necessitate the use of less rigorous evidence. An analysis of cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giugliani, Roberto, Westwood, Stephanie, Wellhoefer, Hartmann, Schenk, Jörn, Gurevich, Andrey, Kampmann, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Genética 2018
Materias:	Human and Medical Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415596/ https://www.ncbi.nlm.nih.gov/pubmed/30334566 http://dx.doi.org/10.1590/1678-4685-GMB-2017-0345

Ejemplares similares

A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. Mol Genet Metab Rep Feb 6 2019
por: Gurevich, Andrey, et al.
Publicado: (2019)

Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
por: Viana, Gustavo M., et al.
Publicado: (2011)

Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2014)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients
por: Müller, Karen B., et al.
Publicado: (2012)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Neonatal screening for four lysosomal storage diseases with a digital microfluidics platform: Initial results in Brazil
por: Camargo, Eurico, et al.
Publicado: (2018)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease
por: Halfmann, Moritz C., et al.
Publicado: (2022)

Population analysis of the GLB1 gene in South Brazil
por: Baiotto, Cléia, et al.
Publicado: (2011)

COVID-19 impact on the diagnosis of Inborn Errors of Metabolism: Data from a reference center in Brazil
por: Sebastião, Fernanda Medeiros, et al.
Publicado: (2021)

Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation
por: Zhou, Guang-Wei, et al.
Publicado: (2022)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy
por: Heo, Sun Hee, et al.
Publicado: (2017)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
por: Kampmann, Christoph, et al.
Publicado: (2015)

Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays
por: Bender, Fernanda, et al.
Publicado: (2020)

Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
por: Kampmann, Christoph, et al.
Publicado: (2016)

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil
por: Palmero, Edenir I., et al.
Publicado: (2009)

Gene expression evaluation of antioxidant enzymes in patients with hepatocellular carcinoma: RT-qPCR and bioinformatic analyses
por: Alves, Andressa de Freitas, et al.
Publicado: (2021)

Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis
por: Ramaswami, Uma, et al.
Publicado: (2019)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions
por: Josahkian, Juliana Alves, et al.
Publicado: (2021)

Association study of folate-related enzymes (MTHFR, MTR, MTRR) genetic variants with non-obstructive male infertility in a Polish population
por: Kurzawski, Mateusz, et al.
Publicado: (2015)

A functional polymorphism in the paired basic amino acid-cleaving enzyme 4 gene confers osteoarthritis risk in a population of Eastern China
por: He, Jin, et al.
Publicado: (2020)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

Anderson's University, Glasgow
Publicado: (1863)

Henry Scott Anderson
Publicado: (1890)

Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease
por: Simonetta, Irene, et al.
Publicado: (2023)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene
por: Rosa, Reginaldo Cruz Alves, et al.
Publicado: (2020)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_779t1eorl9bi7t592rjm1lacv6